ORGO

22.82% -0.55

시간 외 거래: 1.83 -0.03 -1.61%

Organogenesis Holdings Inc (ORGO)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Organogenesis Holdings Inc

Healthcare (1077)

781-575-0775

85 DAN ROAD, CANTON, MA

최신 SEC 제출 서류

ORGO's Discussions on Twitter

Compare ORGO vs TAK, HLN, TEVA, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ORGO Organogenesis Holdings Inc	1.86	328.12M	514.70M	2.72M	17.08M	-0.1589
TAK Takeda Pharmaceutical Co Adr	17.45	55.69B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.03	43.77B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.36	36.19B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	72.66	32.25B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	538.84	26.29B	3.17B	1.29B	1.01B	27.09

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-06-28	개시	Lake Street	Buy
2024-02-07	개시	Cantor Fitzgerald	Overweight
2023-06-15	개시	Morgan Stanley	Equal-Weight
2023-05-24	업그레이드	BTIG Research	Neutral → Buy
2022-11-10	다운그레이드	BTIG Research	Buy → Neutral
2022-08-10	다운그레이드	Oppenheimer	Outperform → Perform
2020-01-10	개시	SVB Leerink	Outperform
2019-08-26	재개	Credit Suisse	Outperform
2019-05-02	개시	Credit Suisse	Outperform
2019-04-17	개시	Oppenheimer	Outperform
2019-04-11	개시	SunTrust	Buy

Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스

Organogenesis Holdings Inc (ORGO) 재무 분석

Organogenesis Holdings Inc 주식 (ORGO) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Driscoll Michael Joseph	Director	Mar 09 '26	Buy	2.67	10,000	26,688	225,707
NUSSDORF GLENN H	Director	Dec 16 '25	Sale	5.14	200,000	1,027,060	2,565,591

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Compare ORGO vs TAK, HLN, TEVA, ZTS, UTHR

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스

Organogenesis Holdings Inc (ORGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Organogenesis reports positive trial results for wound care product - Investing.com

Organogenesis Announces Published RCT Results Showing Affinity Plus Standard of Care Improves Closure Rates in Complex Venous Leg Ulcers - Quiver Quantitative

Peer-reviewed Affinity trial finds higher closure in leg wounds over 24 months - Stock Titan

ORGO|Organogenesis Holdings Inc|Price:2.390|Chg%:-0.040 - TradingKey

Organogenesis Holdings Inc (ORGO) Cash Flow - TradingKey

ORGO|Organogenesis Holdings Inc|Price:2.550|Chg%:+0.160 - TradingKey

Organogenesis Holdings Inc (ORGO) Balance Sheet - TradingKey

Organogenesis Holdings Inc (ORGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Organogenesis Holdings Inc - TradingKey

Organogenesis Holdings Inc (ORGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Organogenesis Holdings Inc (ORGO) Institutional Confidence - TradingKey

TradingKey - TradingKey

Organogenesis Holdings, Inc. Class A Revenue Breakdown – DUS:2PQ - TradingView

Organogenesis Holdings Inc. (ORGO) stock price, news, quote and history - Yahoo Finance Singapore

Organogenesis Holdings Inc (ORGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

ORGO INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed - TMX Newsfile

Organogenesis Holdings Inc (ORGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

ORGO|Organogenesis Holdings Inc|Price:2.335|Chg%:-0.095 - TradingKey

Organogenesis Holdings (ORGO) Slides 7.8% as Stock Tests Key Support ZoneIV Expansion Alert - dars.gov.et

Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session - Sahm

3 Penny Stocks With Market Caps Over $100M To Consider - simplywall.st

Organogenesis Holdings (ORGO) Slips 1.87% as Resistance Holds; Key Levels in FocusSell Signal Alerts - dars.gov.et

Organogenesis stock trades steadily as wound care margins support outlook - Ad-hoc-news.de

Organogenesis Holdings (ORGO) Surges 7.23% as Stock Finds Traction Above SupportOvernight Profile - dars.gov.et

ORGO Q1 2026 Earnings: EPS Miss by Significant Margin, Stock DeclinesQuarterly Profit Report - dars.gov.et

Organogenesis (ORGO) AGM 2026 Summary - Quartr

Organogenesis (ORGO) Proxy filing Summary - Quartr

Organogenesis (ORGO) Q1 2026 earnings summary - Quartr

Organogenesis (ORGO) Q1 2025 earnings summary - Quartr

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - The Manila Times

Organogenesis Holdings (ORGO) Q1 2026 Earnings: Substantial EPS Miss Pressures SharesEarnings Acceleration Picks - dars.gov.et

Organogenesis Holdings outlines regenerative medicine path as investors weigh long-term growth - ad-hoc-news.de

Organogenesis Amnuvx Gets FDA Review for Knee OA - AllSci

FDA accepts Organogenesis’ application for knee osteoarthritis treatment - Investing.com

FDA accepts Organogenesis’ application for knee osteoarthritis treatment By Investing.com - Investing.com Nigeria

Organogenesis' Biologics License Application for ReNu Accepted by FDA for Review - Moomoo

FDA accepts Organogenesis' Biologics License Ap... - Pluang

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis - The Manila Times

Organogenesis wins FDA review for ReNu, a knee osteoarthritis treatment - Stock Titan

ORGO Q1 2026 Earnings: EPS Misses Estimates Amidst Operational ChallengesCFO Commentary Report - dars.gov.et

ORGO Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesUpward Estimate Revision - dars.gov.et

Enterprise value to revenue forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView

Price to book forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView

Price to sales forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView

Organogenesis | 10-K: FY2025 Annual Report - Moomoo

Enterprise value to EBITDA forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView

Price to earnings forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView

Organogenesis Holdings Inc.(NasdaqCM:ORGO) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com

Price to earnings forward of Organogenesis Holdings, Inc. Class A – LSX:A2PA31 - TradingView

Organogenesis Holdings Inc.(NasdaqCM:ORGO) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Organogenesis Holdings Inc (ORGO) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Organogenesis Holdings Inc 주식 (ORGO) 내부자 거래

ORGO과 유사한 종목